That seemingly harmless rash inside your mouth could be trying to tell you something important about your health. While most people dismiss oral irritations as minor nuisances, medical experts ...

Also known as polymorphic eruption of pregnancy (PEP), it is one of the most common types of rash you can get during pregnancy. Though harmless, it does cause an itchy rash with hive-like bumps on ...

Different types of skin rashes include those caused by allergic reactions, infections, insect bites, or health conditions. Examples include eczema, chickenpox, psoriasis, and shingles. It can be ...

Exposure to chlorine can cause a dry, sore rash that may burn or itch. Over-the-counter products such as hydrocortisone cream and antihistamines can help treat the rash. Chlorine is a chemical ...

The firm sees potential upside for Neurocrine shares with multiple commercial products, including Ingrezza and Crenessity, and late stage programs in schizophrenia and depression, the analyst ...

They're just below thermal burn temperatures, and therefore they're causing changes in the skin and it's resulting in kind of a net-like rash." While the condition often resolves on its own within ...

A foot rash can occur due to an allergic reaction or infection. A person can treat some rashes, such as athlete’s foot and contact dermatitis, with over-the-counter (OTC) medications.

You can’t contract the rash from another person, but the plant’s oil can transfer from your clothing. Hiking and biking in parks and woodlands are popular outdoor activities, but some native ...

But as the cold symptoms progress, one clue the illness is different from common respiratory viruses is a classic red rash. Here’s what to know about measles symptoms, what a measles rash really ...

People often use the terms eczema and dermatitis interchangeably, but “dermatitis” is a broader term that encompasses more than eczema rashes. Keep reading to learn about the differences ...

Competition to Austedo and Xenazine is also looming from Neurocrine Biosciences, whose VMAT2 drug Ingrezza (valbenazine) is already approved to treat tardive dyskinesia with a phase 3 readout in ...